BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9445884)

  • 1. [Case of hepatocellular carcinoma due to interferon therapy of chronic hepatitis C].
    Enomura H; Ogasawara M; Doi K; Endo T; Mori T; Matsuzaki O; Fujimoto Y; Takase K; Nakano T
    Nihon Naika Gakkai Zasshi; 1997 Oct; 86(10):1961-3. PubMed ID: 9445884
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ; Lai LP; Murakami-Mori K
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract]   [Full Text] [Related]  

  • 3. [Recurrence of hepatocellular carcinoma associated with hepatitis C virus after tumor ablation].
    Sakaguchi K; Kobayashi Y; Matsumoto E; Shiratori Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):629-33. PubMed ID: 15359874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract]   [Full Text] [Related]  

  • 5. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
    Tambini R; Quattrini A; Fracassetti O; Nemni R
    J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of ventricular tachycardia occurred during interferon therapy in chronic hepatitis C].
    Omae A; Katayama K; Kakiuchi Y; Okada N; Hijioka Y; Nagai Y; Ito Y; Hagiwara H; Kasahara A; Hayashi N
    Nihon Naika Gakkai Zasshi; 1995 Oct; 84(10):1734-5. PubMed ID: 8537730
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M; Yanaga K; Morizane T; Yanagawa T; Hirakawa M; Ueno Y; Esquivel CO; Mitamura K
    J Gastroenterol; 2003; 38(6):598-602. PubMed ID: 12858850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness of interferon in chronic active hepatitis C.
    Sallie R
    Med J Aust; 1994 Jul; 161(2):169-70. PubMed ID: 8080533
    [No Abstract]   [Full Text] [Related]  

  • 9. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
    Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
    Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Permanent hypothyroidism after interferon-alpha treatment in chronic hepatitis C].
    Fernández Soto ML; Ventosa M; Luna V; Salmerón FJ
    Med Clin (Barc); 1996 Jun; 107(2):76-7. PubMed ID: 8753901
    [No Abstract]   [Full Text] [Related]  

  • 11. [How should hepatitis C be monitored? Monitoring of treated hepatitis C].
    Larrey D
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S99-110. PubMed ID: 9161521
    [No Abstract]   [Full Text] [Related]  

  • 12. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Radical and multimodality therapy for hepatitis C virus-related hepatocellular carcinoma].
    Ikeda K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):821-7. PubMed ID: 7563883
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term prognosis of chronic hepatitis C--special reference to interferon therapy].
    Arakawa Y
    Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):480-5. PubMed ID: 9577579
    [No Abstract]   [Full Text] [Related]  

  • 15. Type C chronic hepatitis with the discovery of a small hepatocellular carcinoma 7 years after successful interferon therapy.
    Tomimatsu M; Endo H; Kitazawa M; Iga D; Fujimoto T; Ohkawa S; Kajiyama H; Katagiri S; Harada N; Yamamoto M; Takasaki K
    J Gastroenterol; 2003; 38(4):395-8. PubMed ID: 12743782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma developed in a patient with chronic hepatitis C after the disappearance of hepatitis C virus due to interferon therapy.
    Inoue M; Ohhira M; Ohtake T; Matsumoto A; Kawashima T; Fujimoto Y; Hasebe C; Ono M; Kohgo Y
    Hepatogastroenterology; 1999; 46(28):2554-60. PubMed ID: 10522040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C.
    Kubo S; Nishiguchi S; Tamori A; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Kuroki T; Kinoshita H
    Hepatogastroenterology; 2000; 47(34):1100-2. PubMed ID: 11020887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
    Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
    An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatments for hepatitis virus C infections].
    Pol S; Fontaine H; Vallet-Pichard A
    Gastroenterol Clin Biol; 2001 Mar; 25(3):287-307. PubMed ID: 11395676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recurrence of hepatocellular carcinoma and its treatment].
    Komechi H; Tutui H; Aramaki T; Ohoya T; Kumazaki T
    Nihon Ika Daigaku Zasshi; 1998 Feb; 65(1):69-72. PubMed ID: 9513372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.